Pregnancy:
Carzomib is not recommended during pregnancy, as it may cause harm to the developing fetus. Women of childbearing potential and male patients with partners of childbearing potential should use effective contraception during treatment and for the period recommended by their doctor after the last dose.
Breastfeeding:
Breastfeeding is not recommended during treatment due to the potential risk to the infant.
Kidney Disorders:
Use with caution in patients with kidney disease. Dose adjustment and regular kidney function monitoring may be necessary.
Liver Disorders:
Patients with liver disease should receive treatment under close medical supervision, and liver function should be monitored regularly.
Heart Disorders:
Inform your doctor if you have heart disease, heart failure, chest pain, irregular heartbeat, or high blood pressure, as Carfilzomib may increase the risk of cardiovascular complications.
Blood Cell Monitoring:
The medicine may reduce red blood cells, white blood cells, and platelets, increasing the risk of anemia, infections, and bleeding. Regular blood tests are essential during treatment.
Infection Risk:
Contact your doctor immediately if you develop fever, chills, sore throat, persistent cough, or other signs of infection.
Bleeding Precautions:
Seek medical attention if you notice unusual bruising, bleeding, black or bloody stools, or prolonged bleeding.
Driving:
Avoid driving or operating machinery if you experience dizziness, fatigue, blurred vision, or drowsiness.
Common Side Effects:
Fatigue, anemia, nausea, fever, low platelet count (thrombocytopenia), and infusion-related reactions. Seek immediate medical care if you experience chest pain, shortness of breath, swelling of the feet, severe allergic reactions, or sudden changes in urine output.
